Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
1.
Neth J Med ; 58(2): 71-5, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11166448

ABSTRACT

We describe a 65-year-old man with a granulomatous hepatitis and a progressive mycotic aneurysm of the abdominal aorta. One year before he received intravesical bacillus Calmette--Guérin (BCG) for carcinoma of the bladder without any complaints. Only post-mortem investigations could confirm that he suffered from a systemic BCG infection. Literature is reviewed for this rare complication.


Subject(s)
Aortic Aneurysm, Abdominal/microbiology , BCG Vaccine/adverse effects , Granuloma, Giant Cell/microbiology , Hepatitis/microbiology , Mycobacterium bovis/pathogenicity , Aged , Aortic Aneurysm, Abdominal/surgery , BCG Vaccine/administration & dosage , DNA, Bacterial , Fatal Outcome , Humans , Immunotherapy, Active/adverse effects , Instillation, Drug , Male , Mycobacterium bovis/isolation & purification , Polymorphism, Restriction Fragment Length , Urinary Bladder Neoplasms/therapy
2.
J Clin Pathol ; 52(2): 129-36, 1999 Feb.
Article in English | MEDLINE | ID: mdl-10396241

ABSTRACT

AIM: To investigate whether anaplastic large cell lymphomas (ALCL) expressing cytotoxic proteins have a relatively worse clinical outcome compared with ALCL lacking a cytotoxic phenotype. METHODS: 59 primary cases of ALCL originating from different sites were investigated by immunohistochemistry for the presence of the cytotoxic proteins T cell intracytoplasmic antigen (TIA-1) and granzyme B in the neoplastic cells. Since site of origin and expression of anaplastic lymphoma kinase (ALK) strongly influence prognosis, the presence of a cytotoxic phenotype was also investigated in relation to the primary site of origin (lymph node, gut, or skin) and ALK expression. The prognostic value was investigated by analysis of overall and relapse-free survival time, including Cox regression analysis. RESULTS: 39 of 59 ALCL (66%) appeared to have a cytotoxic phenotype as shown by expression of TIA-1 or granzyme B or both in the neoplastic cells. The presence of a cytotoxic phenotype did not have any influence on prognosis. Even when the survival data were corrected for site of origin and stage at presentation or were analysed separately for ALK positive and negative cases, no prognostic influence of a cytotoxic phenotype was observed. CONCLUSIONS: In primary biopsies of patients with ALCL, the presence of a cytotoxic phenotype is not related to clinical outcome of the disease.


Subject(s)
Biomarkers, Tumor/metabolism , Lymphoma, Large-Cell, Anaplastic/immunology , Membrane Proteins/metabolism , Proteins , RNA-Binding Proteins/metabolism , Serine Endopeptidases/metabolism , T-Lymphocytes, Cytotoxic/immunology , Adult , Aged , Female , Follow-Up Studies , Granulocyte Colony-Stimulating Factor/metabolism , Granzymes , Humans , Immunoenzyme Techniques , Immunophenotyping , Male , Middle Aged , Neoplasm Proteins/metabolism , Poly(A)-Binding Proteins , Prognosis , Survival Rate , T-Cell Intracellular Antigen-1 , T-Lymphocyte Subsets/immunology
3.
Blood ; 93(8): 2688-96, 1999 Apr 15.
Article in English | MEDLINE | ID: mdl-10194449

ABSTRACT

Systemic (nodal) anaplastic large cell lymphoma (ALCL) is a subgroup of T-cell non-Hodgkin's lymphomas with a relatively favorable clinical outcome. Part of systemic ALCLs harbor a genetic aberration (usually the t(2;5)(p23;q35) translocation) containing the anaplastic lymphoma kinase (ALK) gene at 2p23, which results in aberrant expression of the ALK protein. Recently, we have shown that the presence of high percentages of activated cytotoxic T lymphocytes (CTLs) in tumor biopsy specimens of Hodgkin's disease (HD) is associated with a poor prognosis. In the present study, we investigated the prognostic value of percentages of activated CTLs in combination with ALK expression in primary nodal ALCL. Primary nodal biopsies of 42 patients with ALCL were investigated for the percentage of activated CTLs (quantified using Q-PRODIT) and the expression of ALK by immunohistochemistry using monoclonal antibodies (MoAbs) directed against T-cell antigen granzyme B (GrB) and ALK, respectively. These parameters were evaluated for their predictive value regarding progression-free and overall survival time. The presence of a high percentage of activated CTLs (ie, >/=15%) was found to be an unfavorable prognostic marker. In combination with a lack of ALK expression, it was possible to identify a group of patients with a very poor prognosis. In this group, 13 of 16 patients died within 2 years as a result of the disease. Of the remaining 26 patients, only three (all ALK negative) died (P <.0001). Furthermore, the percentage of activated CTLs combined with ALK status appeared to be of stronger prognostic value than the International Prognostic Index (IPI). We conclude that a high percentage of activated CTLs present in biopsy material of patients with primary nodal ALCL is a strong indicator for an unfavorable clinical outcome. The combination of ALK expression and percentage of activated CTLs appears to be more sensitive than the IPI in identifying a group of patients with a highly unfavorable clinical outcome who may be eligible for alternative (high dose) therapy schemes.


Subject(s)
Lymphocyte Activation , Lymphoma, Large B-Cell, Diffuse/immunology , Lymphoma, Large B-Cell, Diffuse/therapy , T-Lymphocytes, Cytotoxic/immunology , Anaplastic Lymphoma Kinase , Antibodies, Monoclonal , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Chromosomes, Human, Pair 2 , Chromosomes, Human, Pair 5 , Combined Modality Therapy , Female , Granzymes , Humans , Lymph Nodes/immunology , Lymph Nodes/pathology , Lymphoma, Large B-Cell, Diffuse/mortality , Lymphoma, Large B-Cell, Diffuse/pathology , Male , Middle Aged , Neoplasm Staging , Protein-Tyrosine Kinases/analysis , Protein-Tyrosine Kinases/genetics , Receptor Protein-Tyrosine Kinases , Recurrence , Retrospective Studies , Serine Endopeptidases/analysis , Serine Endopeptidases/genetics , Survival Rate , Time Factors , Translocation, Genetic , Treatment Outcome
4.
Leukemia ; 12(2): 150-4, 1998 Feb.
Article in English | MEDLINE | ID: mdl-9519776

ABSTRACT

A 54-year-old woman presented with a severe autoimmune anemia, thrombocytopenia, neutropenia (Evans' syndrome), and CD8+ lymphocytosis, without signs of lymphadenopathy or splenomegaly. A diagnosis of T cell large granular lymphocyte (T-LGL) leukemia was made, based on cytomorphology, the typical CD3+/CD4-/CD8+/CD16+/CD56-/CD57-/HLA-DR(+/-) immunophenotype of the lymphocytosis (9 x 10(9)/l), and biallelic clonally rearranged T cell receptor beta (TCR beta) genes. Clonality of the TCR alphabeta+ T-LGL was also demonstrated with a panel of antibodies against variable domains of TCR beta chains, which showed single Vbeta7.1 expression on the CD3+ T-lymphocytes. After treatment failure with corticosteroids, splenectomy, and cyclophosphamide, respectively, a complete clinical remission was induced and sustained with cyclosporin A. Vbeta7.1/CD8/CD3 triple immunofluorescence stainings appeared to be valuable for titrating the cyclosporin A dosage by monitoring the T-LGL cells during treatment.


Subject(s)
Antibodies, Neoplasm/analysis , Antineoplastic Agents/therapeutic use , Cyclosporine/therapeutic use , Immunoglobulin Variable Region/immunology , Leukemia, Lymphoid/drug therapy , Leukemia, T-Cell/drug therapy , Anemia, Refractory/blood , Anemia, Refractory/complications , Female , Genes, T-Cell Receptor beta , Humans , Immunophenotyping , Leukemia, Lymphoid/genetics , Leukemia, Lymphoid/immunology , Leukemia, T-Cell/genetics , Leukemia, T-Cell/immunology , Middle Aged , Neutropenia/blood , Neutropenia/complications , Remission Induction , Thrombocytopenia/blood , Thrombocytopenia/complications
5.
Ned Tijdschr Geneeskd ; 141(10): 457-9, 1997 Mar 08.
Article in Dutch | MEDLINE | ID: mdl-9173284

ABSTRACT

Three patients, men of 39, 27 and 17 years old, who suffered from infectious mononucleosis (Pfeiffer's disease), presented with severe pain in the left upper abdomen radiating to the left shoulder (Kehr's sign). Ultrasonographically an increased amount of abdominal fluid was observed and the spleen ws slightly enlarged. Laparotomy revealed a ruptured spleen. This is a life-threatening complication of infectious mononucleosis.


Subject(s)
Infectious Mononucleosis/complications , Splenic Rupture/etiology , Splenomegaly/etiology , Adolescent , Adult , Humans , Infectious Mononucleosis/diagnosis , Male , Splenectomy , Splenic Rupture/surgery
6.
Eur Respir J ; 8(9): 1616-9, 1995 Sep.
Article in English | MEDLINE | ID: mdl-8575593

ABSTRACT

In 1973, a 10 year old boy presented with numerous bilateral lung nodules, diagnosed as histiocytosis X by open lung biopsy. The patient was treated with prednisone until 1984. In 1993, he developed severe pain in the neck. A biopsy of the spine revealed the same tumour morphology as was seen in the lung in 1973. Immunohistological examination of the former and present biopsy led to the definitive diagnosis of epithelioid haemangioendothelioma of the lung with metastases to spine and liver. Epithelioid haemangioendothelioma of the lung is a rare soft tissue tumour of vascular origin, readily mistaken for carcinoma or, as in this case, histiocytosis. The tumour has an intermediate malignant potential. Although metastases of epithelioid haemangioendothelioma of the lung are well-known, metastatic spread to bones, as in our case, has not previously been mentioned in the literature.


Subject(s)
Hemangioendothelioma/diagnosis , Histiocytosis, Langerhans-Cell/diagnosis , Lung Neoplasms/diagnosis , Spinal Neoplasms/secondary , Antineoplastic Agents/therapeutic use , Biopsy , Child , Diagnostic Errors , Fatal Outcome , Hemangioendothelioma/drug therapy , Hemangioendothelioma/pathology , Hemangioendothelioma/physiopathology , Humans , Lung Neoplasms/drug therapy , Lung Neoplasms/pathology , Lung Neoplasms/physiopathology , Male , Spinal Neoplasms/diagnosis , Spinal Neoplasms/drug therapy
7.
Hautarzt ; 36(2): 107-8, 1985 Feb.
Article in German | MEDLINE | ID: mdl-3988516

ABSTRACT

A case of unilateral nevoid teleangiectatic syndrome (UNTS) occurring during pregnancy is described. Biopsy specimens of the normal skin and of the UNTS were investigated histologically.


Subject(s)
Pregnancy Complications/pathology , Skin Diseases/pathology , Telangiectasis/pathology , Adult , Female , Humans , Pregnancy , Pregnancy Complications/etiology , Receptors, Estrogen , Receptors, Progesterone , Skin/pathology , Skin Diseases/etiology , Syndrome , Telangiectasis/etiology
SELECTION OF CITATIONS
SEARCH DETAIL
...